Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Guiqiang Wang and Peng Peng.
Guiqiang Wang
Connection Strength
0.470
Peng Peng
  1. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. Int Immunopharmacol. 2021 Aug; 97:107702.
    View in: PubMed
    Score: 0.235
  2. The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive. Infect Dis Poverty. 2021 Mar 31; 10(1):45.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.